Skip to main
AMTX
AMTX logo

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

Aemetis Inc. is poised for significant revenue growth, with projections indicating an increase from $398 million in 2025 to $1.8 billion by 2036, reflecting a compound annual growth rate (CAGR) of approximately 14.4%. The company's operations in India are expected to rebound with new contracts this quarter, enhancing overall profitability potential. Additionally, upcoming cash flows from its Renewable Natural Gas (RNG) business and the anticipated initial public offering (IPO) of its biodiesel segment in 2025 could substantially strengthen Aemetis's balance sheet, presenting an attractive investment opportunity.

Bears say

Aemetis Inc. reported a significant decline in revenues from its India operations, with Q4 revenues plummeting to $3 million from $32 million in Q3 2024, highlighting operational challenges in this segment. The company also posted a net loss of $16.2 million for Q4 2024, showing an improvement in per-share loss compared to the previous year, yet still failing to meet both internal estimates and consensus expectations. This ongoing financial underperformance raises concerns about the sustainability and scalability of Aemetis's business model in a competitive renewable fuels market.

Aemetis (AMTX) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Buy based on their latest research and market trends.

According to 8 analysts, Aemetis (AMTX) has a Buy consensus rating as of Jun 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.